Health
Tragedy Strikes: UnitedHealthcare CEO Brian Thompson Shot Dead in Manhattan
A Shocking Incident Rocks the Health Care Industry
In a devastating and unexpected turn of events, Brian Thompson, the 50-year-old CEO of UnitedHealthcare, was tragically killed in a targeted shooting outside a hotel in midtown Manhattan on Wednesday morning. The incident, which has sent shockwaves through the health care industry and beyond, occurred just hours before Thompson was scheduled to address the company’s annual investor conference.
The Incident Unfolds
At approximately 6:45 a.m., Thompson was shot in the chest near the intersection of W. 54th St. and 6th Avenue, outside the Hilton Hotel where the investor conference was set to take place. Eyewitnesses described the scene as chaotic, with the shooter, a white male wearing a ski mask and carrying a backpack, approaching Thompson from behind before firing the fatal shot. The assailant then fled the scene on foot, later using an electric CitiBike to head towards Central Park, where he was last observed.
Thompson was immediately rushed to Mount Sinai West hospital, where he was pronounced dead at 7:12 a.m. The swift and tragic sequence of events has left many in the community reeling.
Investigation Underway
The New York Police Department (NYPD) has launched a comprehensive investigation into the shooting, with Mayor Eric Adams and NYPD officials confirming that the incident was a deliberate and targeted attack. Authorities have recovered three live 9mm rounds and three 9mm shell casings from the scene, and surveillance cameras in the area have captured footage of the suspect.
The NYPD is actively seeking any information that could lead to the identification and capture of the shooter. The suspect is described as a light-skinned male dressed in a light brown or cream-colored outfit, wearing a black face mask and sneakers, and carrying a distinctive grey backpack. A reward of up to $10,000 has been offered for any information that could aid in the apprehension of the perpetrator.
Remembering Brian Thompson
Brian Thompson had been at the helm of UnitedHealthcare since April 2021 and had been with the company since 2004. Prior to his appointment as CEO, he led various key divisions, including government programs such as Medicare and Retirement, as well as Community and State initiatives. Despite his significant role in one of the largest health insurers in the United States, Thompson maintained a relatively low public profile.
Colleagues and industry peers have described Thompson as a dedicated leader and a passionate advocate for healthcare access and innovation. His sudden and tragic death has left a void in the company and the broader health care community.
Company and Community Reaction
In response to the tragedy, UnitedHealth Group, the parent company of UnitedHealthcare, canceled its scheduled investor day. In a statement, the company expressed profound sadness and shock at the loss of their colleague and leader. “We are deeply saddened and shocked at the passing of our dear friend and colleague Brian Thompson, the CEO of UnitedHealthcare. Brian was a highly respected colleague and friend to all who worked with him. We are working closely with the New York Police Department and ask for your patience and understanding during this difficult time. Our hearts go out to Brian’s family and all who were close to him,” the statement read.
Minnesota Governor Tim Walz and Senator Amy Klobuchar have also extended their condolences, with Governor Walz describing the incident as “horrifying news and a terrible loss for the business and health care community in Minnesota.”
Ongoing Manhunt
The NYPD is working tirelessly to apprehend the shooter, with a significant police presence at the scene and parts of the block cordoned off with police tape. The investigation is ongoing, with authorities reviewing evidence and canvassing video footage to identify and bring the individual responsible for the crime to justice.
As the community mourns the loss of Brian Thompson, the focus remains on ensuring the safety and security of the public and bringing justice to his family. This incident serves as a stark reminder of the risks faced by high-profile individuals and the critical role of vigilant law enforcement in protecting society.
The health care industry, known for its resilience and dedication to public service, will undoubtedly come together to support Thompson’s family and continue his legacy of advancing healthcare access and innovation.
Bolanle Media is excited to announce our partnership with The Newbie Film Academy to offer comprehensive courses designed specifically for aspiring screenwriters. Whether you’re just starting out or looking to enhance your skills, our resources will provide you with the tools and knowledge needed to succeed in the competitive world of screenwriting. Join us today to unlock your creative potential and take your first steps toward crafting compelling stories that resonate with audiences. Let’s turn your ideas into impactful scripts together!
Entertainment
Ozempic Era: Beauty, Lizard Venom, Big Pharma

The film industry is entering a new body era, and this time, the co-star is a syringe.
GLP-1 drugs like Ozempic, Wegovy, and Mounjaro have moved from diabetes clinics into casting conversations, red carpets, and agency strategy. In the United States, roughly 1 in 8 adults report having used a GLP-1 drug, with about 6 to 12 percent actively using one today. Globally, usage has surged from approximately 4 million people in 2020 to around 30 million by 2026.
This is no longer a niche health trend. It is a structural shift—one that is reshaping how bodies are constructed, perceived, and rewarded on screen.

At a clinical level, the appeal is clear. In major obesity trials, semaglutide has produced average weight loss of 15 to 17 percent of total body weight over 68 to 104 weeks, with some regimens approaching 19 to 21 percent for sustained users. In an industry built on transformation, those numbers carry real influence.
But rapid transformation leaves a visible trace. The phenomenon often called “Ozempic face”—hollowed cheeks, looser skin, a subtly aged appearance—reflects how quickly fat loss can outpace the skin’s ability to adjust.
For filmmakers, this is not just aesthetic—it is cinematic. Performance lives in the face. Micro-expressions, softness, and facial volume shape how emotion reads on camera. A performer may reach an “ideal” body while losing something less measurable but equally important on screen.
Beneath this cultural shift lies an origin story that feels almost written for film.
In the 1990s, researchers studying the Gila monster isolated a peptide in its venom called exendin-4, which mimicked a human hormone involved in blood sugar regulation but lasted significantly longer in the body. That discovery led to early GLP-1 drugs such as exenatide, used by millions of patients worldwide, and eventually to semaglutide.
By mid-2025, semaglutide-based drugs (including Ozempic and Wegovy) generated approximately $16 to $17 billion in just six months, making it one of the highest-grossing drug classes globally. Analysts project the broader incretin market could reach $200 billion annually by 2030.
Inside those numbers is a more complex human story.
The benefits are well documented: improved blood sugar control, significant weight loss, and reduced cardiovascular risk. But as use expands, so does scrutiny. Researchers and regulators are tracking side effects ranging from severe gastrointestinal issues and gastroparesis to gallbladder disease and pancreatitis, as well as rarer concerns such as vision complications and potential neurological signals.
At the same time, adoption continues to accelerate. J.P. Morgan projects roughly 10 million Americans on GLP-1 drugs by 2025, rising toward 25 to 30 million by 2030. At that scale, usage becomes ambient—part of everyday life across industries, including film and television.
And yet the marketing tells a different story. Pharmaceutical campaigns rely on cinematic language—aspirational visuals, controlled lighting, emotional transformation arcs—while legally required risk disclosures recede into fine print.
For independent filmmakers, this moment opens several narrative lanes.
There is the body: performers navigating an industry where a once-niche diabetes drug has become a quiet career tool.
There is the machine: a pharmaceutical ecosystem where a single drug category generates tens of billions annually, rivaling major entertainment sectors.
And there is the myth: a culture increasingly turning to a hormone-based intervention—derived from venom biology—rather than addressing systemic issues like food access, stress, and inequality.
Technology intensifies all of it. Ultra-high-resolution cameras and HDR workflows capture every detail—skin texture, volume shifts, micro-expressions. As more on-screen talent uses the same class of drugs, a new visual baseline begins to form, often without audiences realizing why.
There is also a clear economic divide. GLP-1 drugs can cost $800 to $1,000 or more per month without insurance in the United States, and coverage remains inconsistent. Rising demand has led to shortages and a parallel market of compounded or unregulated alternatives.

The gap between who can access consistent, medically supervised treatment and who cannot is becoming part of the story itself.
For cinema, the imagery is already there: the Sonoran desert, a Gila monster, laboratory research, pharmaceutical earnings calls, red carpets, and transformation narratives.
A compound derived from venom becomes a global product that reshapes not only bodies, but expectations.
Perhaps the most uncomfortable layer is the industry’s own role. Casting preferences, transformation culture, and unspoken aesthetic standards reinforce a pharmacological look without ever naming it.
No one explicitly instructs performers to take these drugs. The system simply rewards the results.
This is not a distant trend. It is a present-tense shift.
The numbers are rising. The images are changing. The influence is expanding.
The question is whether independent cinema will define this moment while it is still unfolding—or whether the story will once again be shaped by the industries profiting most from it.
Entertainment
Mother’s Day AfroFun Praise Party: Gospel Dance, Fitness & Feel‑Good Stats in 60 Minutes

This Mother’s Day in Spring, Texas, you’re invited to do more than just sit at brunch—come dance, sweat, and celebrate at the Mother’s Day AfroFun Praise Party: Gospel Dance, Fitness & Feel‑Good Stats in 60 Minutes. This one‑hour Afrobeat gospel dance class is for men and women, bringing live worship, high‑energy choreography, and real fitness benefits together in one unforgettable experience.
Live gospel + Afrobeat energy
On the mic is powerhouse gospel singer Shawna Pat, known for her heartfelt worship, energetic praise songs, and ministry that makes every room feel like church and concert at the same time. She’ll be leading live vocals all class long, turning each track into a moment to sing along, shout, or just soak in the presence while you move.
On the floor, Andrew from WoWo Boyz and the Kingdrewwskyy crew bring the Afrobeat power. Expect easy‑to‑follow, Afro‑inspired choreography that looks hype on video but still feels doable if you’re brand new to dance. Together, Shawna and Andrew create a “praise party meets fitness class” vibe you can’t get from a playlist or a regular gym session.
A co‑ed Mother’s Day celebration that counts
This event is built for men and women—moms, dads, sons, daughters, couples, and friends who want to honor the mothers in their lives while doing something healthy and fun. The format is simple: warm‑up, dance‑cardio, a short ministry moment focused on mothers and families, and a cool‑down to breathe and stretch it out.
All levels are welcome. If you can walk and two‑step, you can do this class. You choose your intensity: go all‑in with every jump or keep it low‑impact and still stay in the groove. The music is clean and faith‑filled, so you never have to worry about lyrics or the vibe if you’re inviting church friends or bringing teens.
The feel‑good fitness stats
Behind the fun, this one hour delivers real health wins. Health guidelines recommend at least 150 minutes of moderate‑intensity cardio per week, but less than half of adults hit that number. AfroFun helps close that gap—by making movement feel like a celebration instead of a chore.
In just 60 minutes, many people can:
- Hit 4,000–6,000+ steps, based on what similar dance‑fitness and Mother’s Day cardio sessions log in under an hour.
- Spend solid time in their heart‑healthy zone, where cardio actually strengthens the heart and builds endurance.
- Knock out a big chunk of their weekly 150‑minute cardio goal in one fun, faith‑filled session.
You walk out with more than photos and memories—you leave with better numbers for your heart, body, and mood.
Get your tickets
AfroFun Praise Party happens Sunday, May 10, 4–5 PM at 2400 FM 2920, Spring, TX 77388, with free parking and in‑person, high‑energy vibes. Tickets are limited, and early spots always move fastest once people see Shawna Pat and WoWo Boyz are in the building.
Film Industry
Why Burnt-Out Filmmakers Need to Unplug Right Now

If you’re reading this at 2 AM, scrolling through industry news instead of writing your script, you already know something’s wrong.
You’re not lazy. You’re not untalented. You’re burnt out—and you’re far from alone.

The Numbers Don’t Lie
87% of film and TV workers are facing mental health challenges right now. 62% of creators report burnout, with 65% constantly obsessing over content performance. Even more alarming: 1 in 10 creators experience suicidal thoughts—nearly twice the rate of the general population.
But here’s what the statistics don’t capture: the paralysis. The endless scrolling. The “should I make a feature or pivot to vertical shorts?” loop that keeps you stuck for months. The guilt of watching tutorials instead of shooting. The way political chaos and industry upheaval make creating feel pointless.
The Trap You’re In
You’re waiting. Waiting for the algorithm to make sense. Waiting for the industry to be “fair” again. Waiting for the perfect format, the right budget, the ideal moment when your head is finally clear enough to make something worthy.
That moment isn’t coming.
The filmmakers you admire didn’t wait for perfect conditions. They made their breakthrough films during recessions, pandemics, personal crises, and industry chaos. The only difference between them and you right now? They gave themselves permission to create imperfectly.
Why Now Is Actually the Perfect Time
The industry’s chaos is real, but it’s also created an opening. Streaming platforms are hungry for authentic stories. Independent films are driving growth in the global film market. In 2026, filmmakers with deep trust in a niche have more power than studios chasing mass appeal.
But none of that matters if you’re too exhausted to pick up a camera.

The 3-Day Reset
Here’s what actually helps when you’re stuck:
Day 1: News blackout during creative hours. Not forever. Just when you’re supposed to be creating. The world will still be chaotic tomorrow—but you’ll have protected the only hours that matter for your art.
Day 2: Pick one format. Just one. Feature, shorts, or vertical content—it doesn’t matter which. What matters is ending the analysis paralysis. Your first project won’t be your breakthrough anyway. It’ll be your fifth. So start.
Day 3: Make something imperfect this week. Not good. Not portfolio-worthy. Just made. A 60-second test. A rough scene. Anything that reminds you why you started doing this in the first place.
The Real Problem Isn’t Your Idea
You don’t have a creativity problem. You have an input-overload problem. Your brain is processing election cycles, algorithm changes, industry layoffs, and the constant pressure to “choose the right path” before you’re “allowed” to create.
But creativity doesn’t work on permission slips.
72% of film and TV professionals say the industry is not a mentally healthy place to work. 59% struggle to maintain any work-life balance. 50% face relentless, unrealistic timelines. The system is designed to burn you out.
Your response can’t be to wait for the system to fix itself. It has to be to protect your creative energy like it’s the most valuable resource you have—because it is.
What Happens If You Don’t Reset
The filmmakers who “wait for the right time” never make their films. They become the people who talk about the script they’re “working on” for five years. They’re the ones who know every piece of gear, every distribution strategy, every festival deadline—but have nothing to submit.
Don’t let information replace creation. Don’t let the news cycle steal your narrative.

Start Monday
Not when things calm down. Not when you figure out the perfect format. Not when the industry is “fair” again.
Monday. Imperfectly. With whatever you have.
Your story—messy, unpolished, and made anyway—is what the world needs right now. Not your perfectly researched plan. Not your anxiety about choosing wrong.
Your work.
The filmmakers who win in 2026 won’t be the ones who waited for permission. They’ll be the ones who created despite the noise, shipped despite the doubt, and remembered that done beats perfect every single time.
So take the weekend. Unplug from the chaos. Rest without guilt.
Then Monday morning, make something imperfect.
The industry doesn’t need you to wait until you’re ready. It needs you to start before you feel ready—and figure it out as you go.
That’s not reckless. That’s how every film you’ve ever loved actually got made.
If this hit home, you’re not alone. Thousands of independent filmmakers are choosing to create despite the overwhelm. Start your 3-day reset Monday. Your future self will thank you.
Advice1 week agoHow to Make Your Indie Film Pay Off Without Losing Half to Distributors
Advice1 week agoHow to Find Your Voice as a Filmmaker
Business3 weeks agoWhat the Michael Biopic Means for Every Indie Filmmaker
Business2 weeks agoGLOBAL SUSTAINABILITY SUMMIT RETURNS FOR ITS 5TH EDITION AT THE BRITISH PARLIAMENT – HOUSE OF LORDS, PALACE OF WESTMINSTER
News1 week agoCan AI Really Steal Your Fingerprints From a Selfie?
Film Industry1 week agoActors Win AI Deal – But Your Face Is Still Training the Machine
Entertainment5 days agoOzempic Era: Beauty, Lizard Venom, Big Pharma
Business5 days agoBuilding a 10 Million Army: One Leader’s Mission to Save Tomorrow




















